Home › Cases › Small Volume, Big Decision
Massive Haemoptysis
Small Volume, Big Decision
6 questions
Question 1 · The overnight bleep
Correct answer: This is not massive haemoptysis, but it needs assessment rather than reassurance
Why
Not massive — no hypoxia, no haemodynamic compromise, no airway threat. The physiology is what defines massive, and hers is intact.
But haemoptysis on an anticoagulant in an 81-year-old is not a nothing. It needs a review, a set of bloods, a CXR and a decision about the rivaroxaban.
And small-volume bleeding is sometimes the sentinel bleed before a larger one, which is the reason not to file it under reassurance.
Key point
Not massive, but not nothing. Physiology defines massive; anticoagulation defines the urgency of review.
Question 2 · The anticoagulant
Correct answer: Hold it, assess bleeding risk against stroke risk, and escalate if bleeding continues
Why
Hold it and think, rather than hold it and forget. The decision balances her stroke risk in AF against ongoing bleeding, and that is a discussion with a senior — not one to leave as an unexplained omission for the day team to discover.
Reversal is for major bleeding, and two teaspoons in a stable patient is not that. Reversal agents carry their own thrombotic risk.
Send FBC, U&E and clotting, and check renal function, because DOAC handling depends on it.
Key point
Hold and reassess deliberately. Reversal is for major bleeding, not for a stable small bleed.
Question 3 · What else to look for
Correct answer: A urine dipstick
Why
Dipstick the urine. Haemoptysis with an AKI and blood and protein on dipstick is a pulmonary-renal syndrome until excluded — a same-day renal and rheumatology conversation, and an entirely different disease from a bleed on a DOAC.
It takes a minute and it is not part of anyone's reflex haemoptysis work-up, which is exactly why it is worth naming.
Her age and anticoagulation make a drug-related bleed likely, but likely is not the same as checked.
Key point
Dipstick the urine in haemoptysis. It is how pulmonary-renal syndrome gets found.
Question 4 · The morning
Correct answer: Respiratory follow-up with consideration of CT, because a normal CXR does not exclude a cause
Why
A normal chest radiograph does not exclude malignancy or bronchiectasis — a central tumour can be invisible on a plain film, and the normal result is what most often closes a case wrongly.
She is 81 with unexplained haemoptysis, so the suspected cancer pathway applies on age alone — NICE NG12 sets it at 40 or over, regardless of smoking history.
Recurrent small-volume bleeding needs a CT, not reassurance.
Key point
A normal CXR does not exclude the cause. Recurrent bleeding earns a CT.
Question 5 · If it had gone the other way
Correct answer: Lie her with the bleeding side down, and call critical care, respiratory and IR in parallel
Why
Position and calls. Patients with life-threatening haemoptysis drown before they exsanguinate, so a known bleeding lung goes down to protect the good one. Establish the side first — ask which side feels wet, listen, use the CXR — and do not guess if it is genuinely unknown.
Critical care, respiratory and interventional radiology in parallel — a small group who all need to know at once.
Tranexamic acid — 1g IV or 500mg nebulised — is reasonable and low risk, and urgent reversal of the rivaroxaban now genuinely matters, because this has become major bleeding. Neither displaces the position or the calls.
Key point
Known bleeding side downwards, and all the calls at once. Everything else follows those two.
Question 6 · The handover
Correct answer: That the rivaroxaban is held, why, and who needs to make the decision about restarting
Why
A held anticoagulant with no owner is how a stroke happens on day 3. The handover needs the fact, the reason, and the name of who decides.
The volume is worth recording but is not the decision. "Reviewed and stable" describes last night and carries nothing forward.
The same instruction applies to the investigation plan: somebody has to own the follow-up for her haemoptysis, or the normal CXR becomes the end of it.
Key point
Hand over held anticoagulants with an owner and a decision point.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.